ICL Group Ltd (ICL)
Price:
5.08 USD
( + 0.02 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
FMC Corporation
VALUE SCORE:
7
2nd position
CF Industries Holdings, Inc.
VALUE SCORE:
9
The best
Nutrien Ltd.
VALUE SCORE:
9
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
ICL Group Ltd, together with its subsidiaries, operates as a specialty minerals and chemicals company worldwide. It operates in four segments: Industrial Products, Potash, Phosphate Solutions, and Innovative Ag Solutions (IAS). The Industrial Products segment produces bromine out of a solution that is a by-product of the potash production process, as well as bromine-based compounds; produces various grades of potash, salt, magnesium chloride, and magnesia products; and produces and markets phosphorous-based flame retardants and other phosphorus-based products. The Potash segment extracts potash from the Dead Sea; mines and produces potash and salt; produces Polysulphate; produces, markets, and sells magnesium and magnesium alloys, as well as related by-products, including chlorine and sylvinite; and sells salt. The Phosphate Solutions segment uses phosphate commodity products to produce specialty products; produces and markets phosphate-based fertilizers, as well as sulphuric acid, green phosphoric acid, and phosphate fertilizers; and manufactures thermal phosphoric acid for various industrial end markets, such as oral care, cleaning products, paints and coatings, water treatment, asphalt modification, construction, and metal treatment. It also develops and produces functional food ingredients and phosphate additives for use in the processed meat, poultry, seafood, dairy, beverage, and baked goods markets; and produces milk and whey proteins for the food ingredients industry. The IAS segment develops, manufactures, markets, and sells fertilizers based primarily on nitrogen, potash, and phosphate, including water soluble specialty, liquid, soluble, and controlled-release fertilizers. It sells its products through marketing companies, agents, and distributors. The company was formerly known as Israel Chemicals Ltd. and changed its name to ICL Group Ltd in May 2020. The company was founded in 1968 and is headquartered in Tel Aviv, Israel.
NEWS
ICL Group Ltd (ICL) Q3 2025 Earnings Call Transcript
seekingalpha.com
2025-11-12 14:41:37ICL Group Ltd ( ICL ) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants Peggy Tharp - Vice President of Global Investor Relations Elad Aharonson - President & CEO Aviram Lahav - Chief Financial Officer Conference Call Participants Benjamin Theurer - Barclays Bank PLC, Research Division Kevin Estok - Jefferies LLC, Research Division Joel Jackson - BMO Capital Markets Equity Research Presentation Operator Good morning, ladies and gentlemen, and welcome to ICL Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Wednesday, November 12, 2025.
ICL Group (ICL) Beats Q3 Earnings Estimates
zacks.com
2025-11-12 08:06:13ICL Group (ICL) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.11 per share a year ago.
ICL Reports Third Quarter 2025 Results and Announces New Strategic Principles
businesswire.com
2025-11-12 02:17:00TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the third quarter ended September 30, 2025. Consolidated sales were $1.9 billion, up $100 million versus the prior year. Operating income was $230 million versus $214 million in the third quarter of last year, with adjusted operating income of $241 million versus $243 million. For the third quarter, net income attributable to sharehold.
ICL Group: More Attractive, But Still A 'Hold' Before Q3
seekingalpha.com
2025-11-10 03:34:05ICL Group is fundamentally strong, conservatively managed, and offers a well-covered 3.3% yield, but current valuation limits upside. ICL's strengths include low debt, leading bromine production costs, and diversified specialty chemicals, yet sector volatility and weak near-term growth persist. At $5.64/share, ICL is rated a HOLD, with an unchanged fair value and price target for a 15% annualized return.
ICL Announces Third Quarter 2025 Earnings Call
businesswire.com
2025-10-15 16:30:00TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release third quarter 2025 results prior to the opening of the TASE market on Wednesday, November 12, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30.
ICL to Participate in Fireside Chat at Jefferies Industrials Conference 2025
businesswire.com
2025-08-25 16:15:00TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced Anantha Desikan, executive vice president and chief innovation and technology officer of ICL, will be presenting at the Jefferies Industrials Conference 2025 at 4:10 p.m. ET on Wednesday, September 3, 2025. A webcast of the event will be available at https://investors.icl-group.com/reports-news-and-events/default.aspx#events-presentations. A replay will be ava.
Israel Corp. Reports Results for Second Quarter of 2025
prnewswire.com
2025-08-13 12:23:00TEL AVIV, Israel , Aug. 13, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its second quarter results for the period ending June 30, 2025.
ICL Group Ltd (ICL) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-06 22:00:31ICL Group Ltd (NYSE:ICL ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants Aviram Lahav - Chief Financial Officer Elad Aharonson - President & CEO Peggy Reilly Tharp - Vice President of Global Investor Relations Conference Call Participants Benjamin M. Theurer - Barclays Bank PLC, Research Division Joel Jackson - BMO Capital Markets Equity Research Kevin Estok - Jefferies LLC, Research Division Operator Good morning, ladies and gentlemen, and welcome to the ICL Second Quarter 2025 Earnings Conference Call.
ICL Group (ICL) Q2 Earnings and Revenues Beat Estimates
zacks.com
2025-08-06 08:06:11ICL Group (ICL) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.1 per share a year ago.
ICL Reports Second Quarter 2025 Results
businesswire.com
2025-08-06 02:06:00TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2025. Consolidated sales were $1.8 billion, up ~$80 million versus the prior year. Operating income was $181 million versus $211 million of operating income in the second quarter of last year, with adjusted operating income of $201 million versus $225 million. For the second quarter, net income attribu.
ICL Announces Second Quarter 2025 Earnings Call
businesswire.com
2025-07-09 16:15:00TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release second quarter 2025 results prior to the opening of the TASE market on Wednesday, August 6, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv).
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
prnewswire.com
2025-07-08 07:00:00REHOVOT, Israel , July 8, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology to drive innovation in life-science product development, today announced the successful completion and closing of the previously disclosed transaction involving the divestiture of the majority of the activities and assets of its ag-biologicals subsidiary, Lavie Bio Ltd.
Israel Corp. Reports Results for First Quarter of 2025
prnewswire.com
2025-05-21 14:45:00TEL AVIV, Israel , May 21, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its first quarter results for the period ending March 31, 2025.
ICL Group's Earnings Surpass Estimates, Revenues Lag in Q1
zacks.com
2025-05-21 07:20:40ICL sees higher sales across its Industrial Products, Phosphate Solutions and Growing Solutions units in Q1.
ICL Group Ltd (ICL) Q3 2025 Earnings Call Transcript
seekingalpha.com
2025-11-12 14:41:37ICL Group Ltd ( ICL ) Q3 2025 Earnings Call November 12, 2025 8:30 AM EST Company Participants Peggy Tharp - Vice President of Global Investor Relations Elad Aharonson - President & CEO Aviram Lahav - Chief Financial Officer Conference Call Participants Benjamin Theurer - Barclays Bank PLC, Research Division Kevin Estok - Jefferies LLC, Research Division Joel Jackson - BMO Capital Markets Equity Research Presentation Operator Good morning, ladies and gentlemen, and welcome to ICL Third Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Wednesday, November 12, 2025.
ICL Group (ICL) Beats Q3 Earnings Estimates
zacks.com
2025-11-12 08:06:13ICL Group (ICL) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.11 per share a year ago.
ICL Reports Third Quarter 2025 Results and Announces New Strategic Principles
businesswire.com
2025-11-12 02:17:00TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the third quarter ended September 30, 2025. Consolidated sales were $1.9 billion, up $100 million versus the prior year. Operating income was $230 million versus $214 million in the third quarter of last year, with adjusted operating income of $241 million versus $243 million. For the third quarter, net income attributable to sharehold.
ICL Group: More Attractive, But Still A 'Hold' Before Q3
seekingalpha.com
2025-11-10 03:34:05ICL Group is fundamentally strong, conservatively managed, and offers a well-covered 3.3% yield, but current valuation limits upside. ICL's strengths include low debt, leading bromine production costs, and diversified specialty chemicals, yet sector volatility and weak near-term growth persist. At $5.64/share, ICL is rated a HOLD, with an unchanged fair value and price target for a 15% annualized return.
ICL Announces Third Quarter 2025 Earnings Call
businesswire.com
2025-10-15 16:30:00TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release third quarter 2025 results prior to the opening of the TASE market on Wednesday, November 12, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30.
ICL to Participate in Fireside Chat at Jefferies Industrials Conference 2025
businesswire.com
2025-08-25 16:15:00TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced Anantha Desikan, executive vice president and chief innovation and technology officer of ICL, will be presenting at the Jefferies Industrials Conference 2025 at 4:10 p.m. ET on Wednesday, September 3, 2025. A webcast of the event will be available at https://investors.icl-group.com/reports-news-and-events/default.aspx#events-presentations. A replay will be ava.
Israel Corp. Reports Results for Second Quarter of 2025
prnewswire.com
2025-08-13 12:23:00TEL AVIV, Israel , Aug. 13, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its second quarter results for the period ending June 30, 2025.
ICL Group Ltd (ICL) Q2 2025 Earnings Call Transcript
seekingalpha.com
2025-08-06 22:00:31ICL Group Ltd (NYSE:ICL ) Q2 2025 Earnings Conference Call August 6, 2025 8:30 AM ET Company Participants Aviram Lahav - Chief Financial Officer Elad Aharonson - President & CEO Peggy Reilly Tharp - Vice President of Global Investor Relations Conference Call Participants Benjamin M. Theurer - Barclays Bank PLC, Research Division Joel Jackson - BMO Capital Markets Equity Research Kevin Estok - Jefferies LLC, Research Division Operator Good morning, ladies and gentlemen, and welcome to the ICL Second Quarter 2025 Earnings Conference Call.
ICL Group (ICL) Q2 Earnings and Revenues Beat Estimates
zacks.com
2025-08-06 08:06:11ICL Group (ICL) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to earnings of $0.1 per share a year ago.
ICL Reports Second Quarter 2025 Results
businesswire.com
2025-08-06 02:06:00TEL AVIV, Israel & ST. LOUIS--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today reported its financial results for the second quarter ended June 30, 2025. Consolidated sales were $1.8 billion, up ~$80 million versus the prior year. Operating income was $181 million versus $211 million of operating income in the second quarter of last year, with adjusted operating income of $201 million versus $225 million. For the second quarter, net income attribu.
ICL Announces Second Quarter 2025 Earnings Call
businesswire.com
2025-07-09 16:15:00TEL AVIV, Israel--(BUSINESS WIRE)--ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, today announced it plans to release second quarter 2025 results prior to the opening of the TASE market on Wednesday, August 6, 2025. On that day, Elad Aharonson, president and CEO of ICL, and Aviram Lahav, CFO of ICL, will host a conference call to discuss results, provide a general business update and answer questions at 8:30 a.m. New York time (1:30 p.m. London and 3:30 p.m. Tel Aviv).
Evogene Announces Completion of Transaction for the Sale of Lavie Bio's Activity to ICL
prnewswire.com
2025-07-08 07:00:00REHOVOT, Israel , July 8, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company utilizing cutting-edge artificial intelligence and predictive biology to drive innovation in life-science product development, today announced the successful completion and closing of the previously disclosed transaction involving the divestiture of the majority of the activities and assets of its ag-biologicals subsidiary, Lavie Bio Ltd.
Israel Corp. Reports Results for First Quarter of 2025
prnewswire.com
2025-05-21 14:45:00TEL AVIV, Israel , May 21, 2025 /PRNewswire/ -- Israel Corporation Ltd. (TASE: ILCO) ("ILCO") announced today its first quarter results for the period ending March 31, 2025.
ICL Group's Earnings Surpass Estimates, Revenues Lag in Q1
zacks.com
2025-05-21 07:20:40ICL sees higher sales across its Industrial Products, Phosphate Solutions and Growing Solutions units in Q1.